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Abstract
Continuous-time Markov processes with a ﬁnite state space can be used to model countless
real world phenomena. Therefore, researchers often encounter the problem of estimating
the transition rates that govern the dynamics of such processes. Ideally, the estimation
of transition rates would be based on observed transition times between the states in the
model, i.e., on continuous-time observation of the process. However, in many practical
applications only the current status of the process can be observed on a pre-deﬁned set
of time points (discrete-time observations).
The estimation of transition rates is considerably more challenging when based on
discrete-time data as compared to continuous observation. The diﬃculty arises from
missing data due to the unknown evolution of the process between the actual observation
times. To be able to estimate the rates reliably, additional constraints on how they vary
in time will usually be necessary.
A real world application considered in this thesis involves the asymptomatic carriage
state (colonisation) with the bacterium Streptococcus pneumoniae (the pneumococcus).
The pneumococcus has over 90 strains and for understanding the dynamics of the pneu-
mococcus among humans it is important to understand within-host competition between
these strains. Research questions regarding competition in this thesis are: does colonisa-
tion by one serotype protect from acquisition of other serotypes and is clearance aﬀected
by concurrent colonisation by other serotypes? A question regarding the implication of
competition to pneumococcal dynamics after vaccination is also of interest. In addition,
vaccine protection may be heterogeneous across individuals, leading to a question about
how well such vaccine protection can be estimated from discrete-time data.
When only discrete-time observations are available, the decision when to measure the
current status of the process is particularly important. With measurements that are
temporally apart from each other, information about the state of the process at one point
does not give information about the state at the other points. When measurements are
very close to each other, knowing the state at one point bears information about the state
at other, temporally close points.
This thesis addresses the estimation of transition rates based on repeated observations
of the current status of an underlying continuous-time Markov process. Applications to
actual data concern the process of pneumococcal colonisation. Optimal study designs
are considered for improved future studies of similar type, applications including but not
limited to pneumococcal colonisation studies.
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1 Introduction
The application of statistics in medicine has its foundations in probability theory, greatly
inﬂuenced by Pierre de Fermat (1601 - 1665) and Blaise Pascal (1623 - 1662), and in the
general principles of statistical inference with signiﬁcant contributions by Carl Friedrich
Gauss (1777 - 1855), Thomas Bayes (1702 - 1761), Ronald Fisher (1890 - 1962), and Jerzy
Neyman (1894 - 1981). One of the earliest who applied statistical methods in medicine
was John Snow (1818 - 1858) whose spatial analysis of cholera cases revealed that the
central source of this disease was a water well [1]. Since the times of John Snow, the use
of statistics in medicine and epidemiology has dramatically increased up to a point in
which one of the most inﬂuential medical journals chose statistics in medicine as the 4th
most important medical milestone in the past millennium [2].
Dynamic modelling is increasingly popular in epidemiology, particularly in describing
the spread of infectious diseases [3, 4]. The history of using these models dates as far
back as the early 20th century when Ronald Ross described malaria transmission by using
diﬀerence equations [5, 6]. The models introduced by Ross were further investigated
and solved by Alfred Lotka [7, 8]. One of the major conclusions in these works was the
notion of a critical mosquito density below which malaria transmission would not occur.
A little later, based largely on Ross’ pioneering investigations, Kermack and McKendrick
used diﬀerential equations to understand observed patterns of plague epidemics [9]. They
used an SIR model that describes individuals as either susceptible (S), infected (I) or
recovered (R) in a closed homogeneously mixing population and the particular interest
was to determine a threshold (as a function of population size) below which the epidemic
dies out. George MacDonald continued the work of Ross and Lotka, emphasising the
same threshold quantity, the basic reproduction number, nowadays commonly denoted as
R0 [10, 11]. The analyses of R0 also led to practical actions in the form of exterminating
mosquitoes with dichlorodiphenyltrichloroethane (DDT) in order to eliminate malaria
transmission. One of the most common modern examples of interventions aimed to control
infectious diseases are vaccinations. The evaluation of vaccine eﬃcacy and its relation to
the threshold under which the infection will die out is made almost as a matter of routine.
Dynamic models have an important role in these considerations as they help to understand
the long term behaviour of infectious diseases in vaccinated populations.
There is also a long history of using statistical methods in analysing infectious dis-
ease data [12, 13, 14]. An important example are vaccine studies in which the aim is to
estimate the protective vaccine eﬃcacy, usually as the relative reduction in the risk of
infection among the vaccinated in comparison to the unvaccinated [15]. Another example
is model-based estimation that does not rely directly on statistical associations but gives
information about rates of acquisition, transmission or durations of latent and infectious
period of an infection. However, when employing such estimates, it is particularly impor-
tant that the model parameters have correct interpretations, their estimators are unbiased
and have low uncertainties. Consequently, the usability of inference results depends sub-
stantially on the model speciﬁcation, the methods of statistical inference and on the study
design, i.e., how the data were acquired. For instance, when modelling the spread of an
infectious disease in a population using diﬀerential equations, one usually needs a set of
constants that are taken as input parameters. It is common to adopt these constants as
model-based estimates resulting from statistical analysis[16, 17]. Hence, any such input
parameters would need to have a similar interpretation as in the source study, which may
be problematic because of unadjusted confounding or diﬀerent conditioning on inﬂuential
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background variables. Parameter estimators may also have too high uncertainty to make
strong conclusions. With better design of studies, uncertainty in parameter estimates can
be reduced allowing ﬁrmer conclusions to be made.
Early works which emphasised the importance of study designs are The Arrangement
of Field Experiments (1926) and The Design of Experiments (1935) by Fisher. These in-
troduced ideas such as block designs of which one example is the allocation of agricultural
treatments randomly into blocks such that each treatment occurs exactly once in each
row and in each column (Latin square). Using this design instead of completely random
allocation leads to smaller variances for the treatment estimators. Indeed, the minimisa-
tion of the variances of the parameter estimators of interest is a common desideratum in
study design considerations. When the model parameters form a vector, the covariance
matrix is often evaluated as the inverse of the Fisher information, and the minimisation
of the elements of this matrix can be performed in many ways. Based on the choice of
how the multi-dimensional variance is minimised, diﬀerent optimality criteria have been
deﬁned. Examples are the E-optimality that seeks to minimise the variance of the worst
estimated linear combination of the parameters by maximising the minimum eigenvalue of
the Fisher information matrix, and D-optimality that seeks to minimise the volume of the
variance ellipsoid by maximising the determinant. Major contributors to these deﬁnitions
and on early optimisation theory in general include Jack Kiefer (1924-1981), Abraham
Wald (1902-1950) and Jacob Wolfowitz (1910-1981).
Another signiﬁcant contributor to the research of optimal designs, particularly under
linear regression models, was Gustav Elfving (1908-1984). He considered the optimal
allocation of the independent variable Xi in estimating parameters α or β in the model
Yi = α + Xiβ + η, based on observed Yi. The solution proposed for both estimation
problems is that one should only choose the minimum and maximum values of Xi, but
the proportion in which these observations are made depends on whether the aim is to
estimate α or β. Elfving’s solution to the linear design problem does not depend on the
values of the model parameters α and β. In many design problems, however, this is not the
case. In classical approaches it is then common to use a guess for the model parameters
to derive a locally optimal design. In the Bayesian setting, it is natural to integrate over
a parameter range with respect to a prior distribution.
This thesis is about study designs and statistical inference motivated by applications
to infectious diseases. In particular, all applications considered in this thesis involve a
bacterium Streptococcus pneumoniae (the pneumococcus) in two alternative roles. On one
hand, the pneumococcus has motivated important research questions, which ultimately
can be related to disease burden in humans, and statistical methods were employed to
answer these questions. On the other hand, there are several questions related to the
pneumococcus that still require further investigations. In this thesis, design guidelines
are derived to improve longitudinal pneumococcal studies in the future. Speciﬁcally,
studies considered here pertain to pneumocococal colonisation of the human nasopharynx,
an asymptomatic state that precedes disease. Furthermore, in many other applications
discrete-time data are collected in similar manner to learn the dynamics of continuous-
time processes, so the presented design principles apply to other than pneumococcal
colonisation studies as well.
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1.1 Brief description of the pneumococcus
This section introduces some background information of the example pathogen of this the-
sis, the pneumococcus. The pneumococcus is a bacterium that causes high morbidity and
mortality worldwide, especially among young children [18]. A pre-requisite for pneumo-
coccal disease is colonisation of the upper back throat (nasopharynx) [19]. Colonisation of
the nasopharynx is mostly asymptomatic and common in relation to disease that results
when the pneumococcous invades other tissues such as the lungs or bloodstream leading
to a potentially life-threatening condition.
The ultimate goal regarding the pneumococcus is to reduce the burden of disease it
causes worldwide. This has proven to be challenging, much stemming from the multi-
strain nature of the bacterium. The pneumococcus has over 90 subtypes (serotypes or
strains) that diﬀer by their polysaccharide capsule. The capsule lies outside the cell
wall and deﬁnes many properties related to the bacterium’s interaction with the envi-
ronment, e.g. with the human immune system. A particular example of an attempt to
reduce pneumococcal disease burden is vaccination. Indeed, pneucmoccoccal conjugate
vaccines have proven to be eﬃcacious in preventing the most serious forms of disease
caused by serotypes included in the vaccines. However, the current vaccines include anti-
genic components against only 7 −13 serotypes. As pneumococcal conjugate vaccination
also reduces nasopharyngeal colonisation with the vaccine serotypes, it opens a niche for
the non-vaccine types leading to potential replacement in disease as well [20, 21]. The
phenomenon of replacement reﬂects the fact that pneumococcal serotypes do not colonise
the human host independently but actually compete against each other to occupy their
own niche.
Because colonisation is common in relation to disease and the main source of transmis-
sion between humans, it provides good premises to study some important characteristics
of the pneumococcus. These include the dynamics of colonisation in a population, risk
factors for acquiring colonisation (and thus perhaps disease) and within-host competition
between diﬀerent serotypes. As pneumococcal colonisation is considered a necessary step
in the pathogenesis of pneumococcal disease, there may be a rationale to use colonisation
in the evaluation of new vaccines as well [22].
Colonisation is usually detected by placing a calcium alginate swab to the nasophar-
ynx, cultivating the sample on an agar plate, and if found positive for colonisation, the
serotype or serotypes in question can be subsequently determined [23]. The standard
method to detect pneumococcal colonisation has a high sensitivity to indicate whether a
host is colonised. However, in the case of many serotypes simultaneously colonising the
same host, conventional methods do not necessarily perform well in detecting more than
one of these types.
1.2 Pneumococcal colonisation data and general aspects of in-
ference
The process of pneumococcus colonising the human host is often modelled using a Markov
model with a ﬁnite state space [24, 25, 26]. This class of statistical models is common to
all work in this thesis while similar models have a number of other applications as well.
Although bacterial colonisation may not strictly be an on/oﬀ process, the state of an
individual can be thought to change from non-colonised to colonised after the bacterial
growth reaches a certain biologically signiﬁcant threshold. Hence, modelling with a ﬁnite
state space is likely to be suﬃcient for many purposes.
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Regarding applications to pneumococcal colonisation, SIS (susceptible-infected-susceptible)
models in which the infection can be acquired multiple times have been used (e.g. [25, 26]).
This has been based on the fact that innate or acquired immunity do not completely pre-
vent new acquisitions. The simplest model for an infection that can be acquired multiple
times is the basic SIS model with two states that describe whether the individual is in-
fected or susceptible. In our example case, two states do not fully describe the appropriate
dynamics due to the multi-strain nature of the pneumococcus. In addition, it is possible
that two or more strains colonise the same host simultaneously. In practice, common
serotypes are often modelled as individual strains while the rest are pooled into a com-
bined state of rarer serotypes. Simultaneous colonisation with two diﬀerent types may
be included as its own state if the measurements are sensitive enough to detect multiple
colonisation. Simultaneous colonisation with more than two serotypes is rarely observed
or included in the models of pneumococcal colonisation.
The dynamics of colonisation can be described in terms of rates of transitions be-
tween the model states. Typical research questions related to pneumococcal colonisation
involve the estimation of transition rates, covariate eﬀects on those rates, and ratios of
rates between two groups with diﬀerent treatment status. For instance, the baseline haz-
ards of acquisition and clearance, the eﬀect of exposure on acquisition, or comparison of
acquisition rates between vaccinated and unvaccinated groups could be of interest. A par-
ticular motivation for this thesis arises from competition between pneumococcal serotypes.
Here, competition is described as the relative rate of acquiring or clearing colonisation of a
serotype when the host is simultaneously colonised with some other serotype as compared
to the corresponding rates without the presence of any other serotype. Previous studies
with observational data and this type of deﬁnition of competition are limited.
Under models in which the infection can be acquired multiple times it is not possible to
base the estimation of transition dynamics on cross-sectional data. For instance, consider
a two-state model that describes whether the infection is present or not. Cross-sectional
data of the stationary prevalence of the infection are suﬃcient to estimate the ratio of
acquisition and clearance rates of the infection. Alternatively, if one of the rates is ﬁxed
the other can be estimated [27]. The situation is similar when estimating rates in a
comparative study based on two groups of subjects (e.g. vaccinated and unvaccinated).
It is possible to estimate such eﬀects from prevalence data by assuming that the eﬀect is
either solely on acquisition (S → I) or clearance (I → S).
In this thesis, statistical inference about the transition rates is based on repeated
measurements of the current status of pneumococcal colonisation in the study subjects.
Continuous-time observations are not available mainly because colonisation does not cause
immediately detectable symptoms. Such asymptomatic nature is not exceptional, how-
ever. For instance, Neisseria meningitidis has a similar asymptomatic colonisation state
[28]. A considerable proportion of inﬂuenza infections do not cause detectable symptoms
either [29].
The current status data are interpretable as a collection of snapshots from the underly-
ing continuous-time status of each individual. Between any two consecutive observations
there is an unobserved part and the path that the process takes between the two ob-
served states remains unobserved (i.e. missing). In particular, one can question whether
the process visited other states during the unobserved period or made a direct transition
from one observed state to another, or even remained in the same state the whole time.
In addition, if a state change occurred, the times of these events are unknown. With a
relatively short time in between the observations, it is likely that only few state changes
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remain unobserved while samples lying temporally apart from each other leave more room
for unobserved events.
When the likelihood of the model parameters under a continuous-time process is based
on current status data, the possibility of unobserved events between the observations needs
to be taken into account. A common approach in applied epidemiology is to assume a
minimum number of transitions (often only one) that makes the observations possible to
occur somewhere between (e.g. midway) the two observed states [30]. This approach is
applied also in Article I. Another extreme is complete treatment of the unobserved part
by integration over all possible events [31]. The diﬃculty of calculating such an integral
depends on how complex time-dependence is allowed for the transition rates. In the
simplest case the transition rates are assumed to be constant. Transition probabilities that
take into account all possible transition paths can then be derived easily [32]. Otherwise,
numerical integration methods have been applied [31]. In Articles II − V it is assumed
that the transition rates are constant in time.
The investigator often has many alternative options to allocate repeated observations
in a study. The optimal allocation of observation times then becomes an important design
question so as to improve how well the study answers to the posed research questions.
For instance, if the problem is to estimate the parameters of a statistical model, one
can ask how the time spacing between consecutive samples aﬀects the bias and variance
of the parameter estimators. With a short time spacing, repeated samples are typically
more correlated than with a long one. With long enough time spacing, observations may
arise almost independently, given the underlying process. It has not been comprehensively
studied how the time spacing and thus the correlation between consecutive samples should
be to obtain unbiased estimators with as small a variance as possible for the quantities of
interest. The main design question considered in this thesis is to determine which time
spacing between zero (highly dependent samples) and inﬁnity (independent samples) is
optimal in to estimate parameters of interest. Design question related to time spacings
between consecutive observations are considered in Articles III, IV and V. Other study
design questions including the total number of samples to be collected, the number of
individuals versus repeated observations from the same individuals and the initial state
of the process to collect the ﬁrst samples are considered in Article III.
Measurements of the current infection status may contain errors or imprecisions. For
instance, because of sampling methods, the infected status may sometimes be incor-
rectly observed as susceptible. The type of infection may also be incompletely identiﬁed.
With pneumococcal colonisation, a particular problem arises when more than one subtype
colonise the same host simultaneously. It is challenging to determine all subtypes present
in the nasopharynx. The analysis of within-host competition between diﬀerent serotypes
is then particularly problematic. In Article II, a hidden Markov model for such incom-
plete observations is considered, and it is studied how the analyses about competition are
aﬀected by the sensitivity to detect simultaneously colonising subtypes.
2 Markov models
Let {ζi(τ); τ ≥ 0}, be a continuous-time stochastic process with a ﬁnite state space
S = {1, ..., n}. The process ζi(τ) describes the state of an individual i at time τ . For
instance, with S = {1, 2}, ζi(τ) could denote whether the individual is susceptible (1)
or infected (2) at time τ . In epidemiology, models of this type are often referred to as
compartmental.
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The dynamics of the process ζi(τ) can be deﬁned in terms of its transition rates:
λj,k(τ) = lim
Δt→0
P(ζi(τ +Δt) = k | ζi(τ) = j)
Δt
,
where j, k ∈ S, j = k, and λk,k = −
∑n
j=1,j =k λk,j. The rates can be represented as an
n×n matrix q(τ), where the (j, k)th element is λj,k(τ). In this thesis, the transition rates
are not allowed to depend on the history of the process but only on the current status
at time τ , i.e. only Markov processes are considered. Further introduction to Markov
processes and their applications can be found e.g. from [33] and [34].
The transition probability that, conditioned on being in state j at time τ, individual
i is in state k after time t has elapsed is denoted by
ptj,k(τ) = P(ζi(τ + t) = k | ζi(τ) = j).
The transition probability matrix with the (j, k)th element ptj,k(τ) is denoted by p
t(τ).
The transition rate matrix generates the transition probabilities for all time intervals t.
In particular, the relation between the transition rates and the transition probabilities
satisﬁes the Kolmogorov forward equations:
dpt(τ)
dt
= pt(τ)q(τ),
with the initial condition p0(τ) = In, the n × n identity matrix. The solution of these
equations can be written as a product integral as follows. Given a partitioning of the
interval (τ, τ + t) into m subintervals according to points τ = t1 < t2 < ... < tm = τ + t,
the transition probability matrix is
pt(τ) = lim
max |ti−ti−1|→0
m∏
i=1
(
I + dp(ti)
)
,
where m increases as max |ti− ti−1| → 0. The term I+dp(ti) is the transition probability
matrix over a short time interval (ti−1, ti) and dp(ti) approaches |ti − ti−1| ×q(ti) as |ti −
ti−1| → 0. The above considerations pose no assumptions about how the transition rates
vary in time. However, without further assumptions, the product integral formulation does
not easily lend to calculating the transition probabilities unless continuous observations
of the process are available.
2.1 Inference with continuous-time data
If the process is observed continuously in time, one can estimate the cumulative transition
rates (i.e. the elements dp(ti)) non-parametrically with the Nelson-Aalen estimator [35,
36]. The empirical transition probability matrix for pt(τ) is then the Aalen-Johansen
estimator, obtained as the product integral of the Nelson-Aalen estimator [37, 38, 39].
The Nelson-Aalen and Aalen-Johansen estimators make no restricting assumptions about
how the rates vary over time.
Parametric approaches based on the likelihood for continuous-time observations are lu-
cidly presented by Andersen and Keiding [40] and more rigorously in [14]. In brief, suppose
that N individuals are observed for time intervals [0, τi], i = 1, ..., N. The probability den-
sity that, conditional on being in state h at time s, one stays in that state until time t > s
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and then moves to another state j at time t is ph,j(s, t) = λh,j(t) exp(−
∫ t
s
∑
k =h λh,k(u)du).
Let N ih,j(τi) denote the number of observed transitions for individual i from state h to j
by during time interval [0, τi]. The corresponding event times are denoted as T
1,i
h,j < ... <
T
N ih,j(τi),i
h,j . The likelihood function of rates λ based on continuous-time data Y from N
independent individuals is
L(λ;Y ) =
N∏
i=1
πi0
n∏
h=1
∏
j =h
N ih,j(τi)∏
k=1
λh,j(T
k,i
h,j) exp
(
−
∫ τi
0
λh,j(u)1
i
h(u)du
)
, (1)
where for individual i, πi0 is the probability of being in the observed state at time 0, and
1ih(u) the indicator of being in state h at time u−, just before time u.
2.2 Likelihood based on current status data
This thesis considers situations in which only current status data are available. With
repeated measurements of each individual’s status, this is equivalent to observing the
frequency of transitions between the model states over ﬁxed time intervals. The interest
is to estimate the rate matrix q(τ) based on these frequencies. For this kind of inference
to be possible, transition probabilities need to be expressed in terms of the transition
rates, which usually requires restricting assumptions about how the rates vary in time.
For a formal presentation, denote the number of individuals by N, the number of sam-
ples collected from individual i by Ki and the observation times by τ
k
i , k = 1, ..., Ki; i =
1, ..., N. Denote the observed data by Y = {Yi(τ ki ); k = 1, ...Ki; i = 1, ..., N}, where Yi(τ ki )
is the state of individual i at time τ ki . If individuals are statistically independent, the joint
probability of these data under the Markovian assumption is
N∏
i=1
P(ζi(τ
1
i ) = Yi(τ
1
i ))
Ki∏
k=2
P(ζi(τ
k
i ) = Yi(τ
k
i )|ζi(τ k−1i ) = Yi(τ k−1i )), (2)
where the initial distribution P(ζi(τ
1
i ) = Yi(τ
1
i )) usually needs its own speciﬁcation. The
probability P(ζi(τ
k
i ) = Yi(τ
k
i )|ζi(τ k−1i ) = Yi(τ k−1i )) is for the transition that the individual
i is in state Yi(τ
k
i ) at time τ
k
i , conditional on being in state Yi(τ
k−1
i ) at time τ
k−1
i . Here,
as always in this thesis, it is assumed that there exists a continuous-time process that
induces the transition probabilities, that is, the process is deﬁned by a rate matrix q(τ). To
emphasise this connection, the transition probability will be denoted as the corresponding
element of the transition probability matrix p(Yi(τ
k−1
i ), Yi(τ
k
i )). The transition probability
matrix is called embeddable if there exists a generating rate matrix. Although it is
assumed that such a rate matrix exists in theory, the sample-based transition frequency
matrix may not always be embeddable [41, 42].
In the following, the rate matrix q is deﬁned through a parameter vector Θ, but the
dependence of q and p on Θ is omitted from the notation for brevity. It also assumed
that the transition rates are constant or piecewise constant in time, so that the induced
transition probability matrix can be calculated from the rates. In particular, when q(τ) =
q for all τ , the transition probability matrix for a time interval of length t is pt = exp(q×t),
where exp refers to the matrix exponential function (exp(q× t) =∑∞i=0((q× t)i)/i!) [43].
The probability of data described by equation (2) with the initial distribution π provides
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the likelihood function of the parameters Θ:
L(Θ;Y ) =
N∏
i=1
π(Yi(τ
1
i ))
Ki∏
k=2
p(Yi(τ
k−1
i ), Yi(τ
k
i )).
A common assumption in modelling the spread of an infection is that the transition
rates for a particular individual depend not only on his or her current status but also on
the status of other individuals. In particular, the rate of acquiring the infection is often
assumed to depend on the current number of infected individuals in the surrounding
population. The state space of the process then needs to entail the joint status of all
individuals. For a population of N individuals, let the process ζ(τ) carry the information
of each individual’s status at time τ . The dimension of the joint state space of the process
ζ(τ) is nN . Because the current status of the population carries information about the
current number of infected individuals, the process is still Markovian. In particular, it is
governed by a transition rate matrix Q of dimension nN ×nN . The transition probability
matrix for the process ζ(τ) is Pt = exp(Q).
In order to write the likelihood for parametersΘ that deﬁneQ, let {τ ki ; j = 1, ..., Ki; i =
1, ...., N} := {τ j; j = 1, ..., l} be the set of distinct observation times from all individuals
in the study population. In case all individuals have not been observed at the same time
points, the process ζ(τ) is only partially observed at least at some time points in the set
{τ j}. Regarding the status of individual i at point τ j, j = 1, ..., l, denote the state by
Yi(τ
j) if it is observed and by xi(τ
j) if it is missing. Let Ri(τ
j) be an indicator function
for whether the status of individual i at τ j is observed. For some realisation of the miss-
ing data x, denote Y x(τ j) = Yi(τ
j) if Ri(τ
j) = 1 and Y x(τ j) = xi(τ
j) if Ri(τ
j) = 0.
The likelihood based on the observed data Y is obtained by summing over all possible
realisations of missing data x:
L(Θ;Y ) =
∑
x
π(Y x(τ 1))
l∏
k=2
P(Y x(τ k−1),Y x(τ k)).
The choice to model discrete-time data using a continuous-time process is deliberate.
It would have been possible to construct discrete-time transition probabilities instead
of using a continuous-time process with its transition rates. However, an advantage of
using continuous-time models is that they lead to estimates of transition rates rather
than transition probabilities, which greatly facilitates the interpretation and comparison
of results across diﬀerent studies not necessarily based on the same sampling frequency.
If studies were based on transition probabilities, rather than transition rates, transition
probability matrices would need to be transformed to pertain to other time spacings.
While transition probabilities for multiples of any given time spacing are obtained by
matrix multiplication, other time spacings require taking matrix roots. The simplest
condition for this to work is that the transition probability matrix (p) is embeddable, i.e.,
the continuous-time process can be constructed based on observed transition probabilities
[44]. In practice, this means that embeddability needs to be assumed in any case. Another
argument favouring the use of transition rates is based on the need to model covariate
eﬀects. It is common to assume that the eﬀects are multiplicative on the transition rates
rather than on transition probabilities.
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2.3 Models for missing data
When the process cannot be observed continuously in time, one has to conﬁne to current
status data observed at predeﬁned time points. The status of the process in between any
two observations can be described as missing by (study) design. The transition probability
matrix for a continuous-time Markov process takes such missingness into account by
deﬁnition. In the following, various other types of missingness are reviewed, together
with a discussion about how they should be taken into account in making statistical
inference.
Based on the mechanism by which the data are considered to remain unobserved,
missing data can be categorised as missing completely at random (MCAR), missing at
random (MAR), or missing not at random (MNAR). These ideas originated from the
seminal work of Rubin [45] and are still widely applicable [46]. To present formal deﬁni-
tions, recall that Ri(τ
j
i ), j = 1, ..., Ki; i = 1, ..., N, is the indicator for whether the status
of individual i at time τ ji is observed. As before, let y denote the observed data and x the
underlying but missing data. Missing completely at random is deﬁned through condition
p(R|x,y) = p(R), saying that the process that produces missing data is independent
of the data, whether these are observed or not. The deﬁnition of missing at random
(MAR) is also an independence condition. In particular, the condition for MAR is that
missing data may depend on the observed part of the data but must not depend on the
unobserved part: p(R|x, y) = p(R|y). In the case of MNAR, whether or not data are
observed depends on the data that remained unobserved.
Let ξ be a parameter vector that governs the process causing missing data. The correct
likelihood for inferring about the model parameters, including ξ, is
L(Θ, ξ;y,R) = p(y,R;Θ, ξ) =
∫
x
p(x, y;Θ)p(R|x, y; ξ)dx.
If the missing data are MCAR or MAR, likelihood-based inferences about Θ can be based
solely on p(y;Θ) =
∫
x
p(x, y;Θ)dx. This follows because under MCAR and MAR, R is
independent of x and hence∫
x
p(x, y;Θ)p(R|x, y; ξ)dx = p(R|y; ξ)
∫
x
p(x, y;Θ)dx.
In the case of MAR, other than strictly likelihood-based inferences may not be correct if
based on
∫
x
p(x, y;Θ)dx. For instance, estimators derived using generalised estimation
equations require MCAR [47] whereas Bayesian methods require only MAR.
If the probability of not observing the status of an individual depends on the status
itself (MNAR), a model for missing data need to be incorporated in the inferences. This
is also the case if the measurement of state Yi(τ
j
i ) can result into an erroneous observation
Y ′i (τ
j
i ) = Yi(τ ji ). Apart from Article II, data are assumed to be missing under MAR. In
Article II, a model is constructed with an additional observational layer that takes into
account the process of how the status of each individual is observed. The observational
layer is needed because in the case of simultaneous colonisation of two pneumococcal
serotypes it is possible that only one of these is observed. This type of missingness
depends on the underlying state of the process and is thus MNAR. The model in Article
II is a hidden Markov model and the likelihood is calculated recursively, similarly to the
Viterbi algorithm [48].
A particular question addressed in Article II is the joint eﬀect of the time spacing
between consecutive measurements and the imperfect sensitivity to detect two simulta-
neously colonising serotypes (MNAR data) on the estimation of within-host competition
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between pneumococcal strains. By simulation, it was shown for various time spacings how
the analyses become biased if MNAR data are not properly accounted for. The simulation
results were used to corroborate the unbiasedness of the ﬁndings about competition from
the analysis of three data sets collected using varying sampling frequencies.
2.4 Parametrisation of transition rates
This section considers parametrisation of the rate matrix q(τ) with a vector Θ of small
dimension. Research questions in this thesis are formulated as problems of estimating Θ.
The dimension of the parameter space requires usually some restrictions as the following
illustrates. In studies of pneumococcal colonisation, possible states include susceptible
and infected by one of the strains (90 or more), totalling to more than 91 possible states.
If all possible pairs of 90 strains are allowed to infect the same host simultaneously, there
are 90×89/2 = 4005 additional states in the model. If all transition rates in a model with
n = 4096 states were treated as distinct parameters, there would be n(n − 1) unknowns
to be estimated.
One way of reducing the number of model parameters is to assume that certain tran-
sitions share the same rate. As a practical example, the average rate of clearance might
be assumed to be the same among some subset of strains. The corresponding clearance
rates could then be modelled using a single model parameter. In Articles I and II, rel-
ative rates, comparing already colonised and susceptible individuals, were parametrised
in terms of a single parameter across all serotypes. For acquisition rates, mechanistic
assumptions can be used to reduce the number of model parameters. For instance, a
common transmission rate parameter (β) may be assumed across many strains, scaled
for a speciﬁc strain according to exposure, i.e., the number of individuals infected with
that strain (ni). Acquisition rates in such cases are of the form niβ. In a large population
where the number of infected individuals is approximately constant in time (steady state)
the whole term (ni/N)β can be modelled with a single parameter.
With regard to exposure, in Article II three diﬀerent data sets on pneumococcal coloni-
sation are employed assuming constant transition rates because information about expo-
sure is not available in all three data sets. It is natural to rise a question of possible
confounding since the research questions consider infectious diseases. Here the aim is to
study between-strain competition deﬁned through rate ratios such as the relative rate
of acquisition of strain A when the host is currently colonised with another strain, as
compared to acquisition (of A) when the host is non-colonised. Exposure to the strain
would be a confounding factor if it is associated with the distribution of the time at-risk
that is spend non-colonised and colonised with other strains that A itself. However, such
associations were not found in the observed data.
Another way to reduce the number of model parameters is state aggregation, meaning
that a group of states is considered as being one pooled state in the model [49]. Regarding
applications to pneumococcal colonisation, commonly observed serotypes are often treated
as their own states while the rest comprise an aggregated state of rarer serotypes (cf.
Articles I and II). This is because the data are often insuﬃcient for the estimation of strain-
speciﬁc rates for the rarely observed types. Another possible motivation for aggregation
is that the actual interest regards the estimation of transition rates between groups of
states. For instance, the interest could be to estimate the total acquisition or clearance
rates of all serotypes, or to estimate the acquisition and clearance rates for two pools
of types, deﬁned according to whether or not the vaccine can provide protection against
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individual serotypes within the pools. Respectively, aggregated models with two and
three states would then be appropriate. This type of aggregation is used in data analyses
of Article V although the underlying model is constructed for a large number of states.
By simulation, theoretical aggregate measures of transition rates are compared to those
obtained by estimation based on aggregate level data.
In Article V, another question of parametrisation regards vaccine eﬀects. In particular,
Article V considers vaccines that may yield protection against a subset of all strains in
the model and vaccine eﬀects may also have diﬀerences at the individual level (random
eﬀects model). The strain-speciﬁc average vaccine eﬀects were allowed to have their own
parameters, but when conditioning on any one individual, the random eﬀect was restricted
to be equal for each strain. In addition, aggregate level vaccine-eﬃcacy measures are
considered to limit the number of estimated parameters.
3 Design aspects and criteria
Suppose plans are made to collect data to answer a speciﬁc research question. In the
design phase of the study, there are often several possible choices regarding how the data
could be collected. These choices often aﬀect how well the study answers the posed
research question. When the research question is formulated as an estimation problem,
the study design may aﬀect the variance and bias of the estimators. The task is to choose
the design so that the variance and bias are minimised.
In this thesis, the interest is in the estimation of the rate matrix q(τ) when only ob-
served transition frequencies over some time intervals are available. There exists some
previous research about optimisation of designs for the estimation of transition rates of
certain types of continuous-time Markov processes based on repeated current status data.
These include the simple birth process [50], the simple death process [51], and the sim-
ple birth-death process [52]. Multistate models have been considered for the analysis of
epidemic data [53]. In the above presented work the processes either die out or grow indef-
initely and thus do not have the ergodic property. Optimal allocation of measurements for
ergodic Markov processes have been considered under the two-state model [27] and under
multi-state models to estimate species migration rates [54]. Comparisons of eﬃciencies of
rate estimators using discrete observations with respect to the continuous one have also
been presented [27, 55]. Optimisation in these work is based on the Fisher information
that depends on the model parameters. Generally, design methodologies aiming to relax
the dependency on a single parameter value include sequential designs [56], use of a prior
distribution [57, 58] and application of the maximin approach [59].
3.1 Utility-based designs
We approach design problems from a utility theoretic point of view, which is common in
Bayesian design [60, 61], and then discuss how these are related to classical approaches in
which the Fisher information is employed. Formally, let η denote a candidate design that
characterises one of the choices andΥ the space of all possible designs. A candidate design
η is evaluated using a utility function U(η,Θ,y) that depends on the model parameters
Θ and on data y yet to be collected. The dependence on y is handled by taking the
expectation over all possible data:
U(η,Θ) =
∫
y
U(η,Θ,y)p(y|Θ, η)dy.
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With regard to dependence on Θ, a common choice is to integrate over a selected prior
distribution:
U(η) =
∫
Θ
U(η,Θ)p(Θ)dΘ.
A special case of a prior is the degenerate distribution: P{Θ = Θ0} = 1, i.e., a single
value of the parameter vector (Θ0). The maximiser of the utility under a degenerate prior
is referred to as the locally optimal design.
The general optimisation task is to maximise the expected utility U(η) in a design space
η ∈ Υ. A common approach in measuring the performance of design η, when concerned
with making inferences about a parameter vector Θ, is to choose the utility function so
that it involves some properties of an estimator Θˆ(y). A natural requirement is that error
of the estimator is minimised. Denoting the parameter vector as Θ = (Θ1, ...,Θd), a
possible utility function aiming to meet this criterion is
U(η) = −
∫
Θ
∫
y
(Θ− Θˆ(y))TW(Θ− Θˆ(y))p(y|Θ, η)p(Θ)dydΘ
= −
∫
Θ
d∑
i=1
wiE[(Θi − Θˆi(y))2]p(Θ)dΘ, (3)
where the expectation is with respect to p(y|Θ, η) and W is a diagonal matrix with
elements w1, ..., wd with wi as a subjectively selected importance weight for the component
i of Θ. In general, the above utility measures the mean squared error which is the sum
of the variance and the squared bias. If the estimator is unbiased then E[(Θi − Θˆi)2] =
Var(Θˆi) and the utility measures the weighted average of variances Var(Θˆi) with weights
wi. Covariances of the parameters (Cov(Θi,Θj)) can be involved in the utility by choosing
a non-diagonal W . In the locally optimal approach, p(Θ) is replaced by an initial guess
of the parameter vector Θ0, so that the utility function becomes
U(η;Θ0) = −
∫
y
(Θ0 − Θˆ0(y))TW (Θ0 − Θˆ0(y))p(y|Θ0, η)dy.
The evaluation of these utility functions can be based on Monte-Carlo integration. In
the locally optimal case, data yc2 , c2 = 1, ..., C2 are repeatedly sampled from p(y|Θ0).
For each sampled data set, an estimate Θˆ0(yc2) is obtained as the maximum likelihood
estimate or the Bayesian posterior mean. The Monte-Carlo approximation of the expected
utility is then
U(η;Θ0) ≈ − 1
C2
C2∑
c2=1
(Θ0 − Θˆ0(yc2))TW (Θ0 − Θˆ0(yc2)).
If a proper prior distribution p(Θ) is used, the only diﬀerence is that the parameter vector
is sampled from the prior instead of using a ﬁxed value. The evaluation of (3) can then
be based on:
U(η) ≈ − 1
C1C2
C1∑
c1=1
C2∑
c2=1
(Θc1 − Θˆc1(yc2))TW (Θc1 − Θˆc1(yc2)),
where Θc1 ∼ p(Θ) and yc2 ∼ p(y|Θc1), c2 = 1, ..., C2, c1 = 1, ..., C1.
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In maximum likelihood estimation, the evaluation of variances is often based on the
Fisher information matrix I (Θ) = (I (Θ)i,j), where
I (Θ)i,j = E
[(
∂
∂Θi
logL(Θ;y)
)(
∂
∂Θj
logL(Θ;y)
)]
and the expectation is taken over data y. The inverse of the Fisher information is the
variance matrix of the asymptotically normally distributed maximum likelihood estima-
tors (Var(Θˆ) = I (Θ)−1). Optimisation of designs when using the Fisher information is
commonly based on the A-, D-, or E-optimality criteria, which seek to minimise the trace
of I (Θ)−1, the determinant of I (Θ), or maximise the minimum eigenvalue of I (Θ),
respectively. The D-optimality criterion can be interpreted as the volume of the variance
ellipsoid of the parameter estimators, and the E-optimality minimises the maximum vari-
ance of normalised linear combinations of the parameter estimators. The A-optimality
criterion minimises the average variance of the model parameters. By choosing W as
the diagonal matrix in (3), the utility corresponds to the trace of Var(Θˆ) for unbiased
estimators and thus asymptotically corresponds to the A-optimality criterion [62].
The above utility functions involve measures related to the general performance of the
estimation, given the study design. An alternative approach can be considered when the
main interest is not in the estimation of a parameter vector Θ but in making predictions.
Utility functions in these cases can be based on some criterion that involves the posterior
predictive distribution p(y′|y, η). Practical limitations related to speciﬁc study settings
can be considered as part of the utility as well. For instance, if the budget of the study is
ﬂexible rather than a strict constraint, sampling cost can be part of the utility function
[57]. Another interesting example is the battery life of a GPS transmitter that submits
the current status of the process and as such built in to the estimation problem [54].
Two-phase designs. In a two-phase study, data are collected in two phases with the
possibility to improve the design for the second phase. The ﬁrst phase data Y 0(η0) = Y
0
are collected using an initial design η0, which can be derived as described above. The
question for the second phase is to optimise design η1 employing the already accumulated
information Y 0.
Let y denote the second phase observations which are to be collected using the second-
phase design η1. For the optimisation of the second phase design, the utility function is
U˜(η1;Y
0) = −
∫
Θ
∫
y
(Θ− Θˆ(y,Y 0))TW (Θ− Θˆ(y,Y 0))T p(y|Θ, η)p(Θ|Y 0)dydΘ. (4)
The above utility function U˜(η1;Y
0) can be used in the optimisation of the second
phase design but not in answering questions such as whether the study should be con-
ducted in one or two phases. This is because data Y 0 in the utility above are already
observed whereas the decision about whether conducting the study in one or two phases
needs to be done before collecting any data. The question of whether the study should
be conducted in one or two phases needs to be answered by comparing a utility U(η0) of
the form (3), in which all data are collected using design η0, to a two-phase utility where
η0 is the same design for the ﬁrst phase and η1 is the second phase design that maximises
(4). Because the ﬁrst phase data are not observed they need to be integrated out. Design
η1 also depends on the ﬁrst phase data, so U(η0) is compared to the utility
U˜(η0) =
∫
Y 0
U˜(η1;Y
0)p(Y 0)dY 0.
21
The distribution p(Y 0) can be speciﬁed e.g. to follow a model with a single value of the
parameter vector p(Y 0|Θ0).
The above presented utility-theoretic approach for the two-phase studies is analogous
with the following approach in which the variance of the model parameters is based on
the Fisher information. The Fisher information for the ﬁrst phase is replaced by the
observed information, i.e., the sample-based information matrix. It can be calculated as
the negative Hessian matrix of the logarithm of the likelihood given the observed data,
denoted −H(Θ0;Y 0). Based on Y 0, a maximum likelihood estimator Θˆ0 is obtained.
The information used to design the second phase with a ﬁxed Y 0 is
−H(Θˆ0;Y 0) + I(Θˆ0;Y 1|Y 0),
where the conditioning Y 1|Y 0 indicates the possibility of a Markovian dependence of the
future data on Y 0.
When considering questions such as whether the study should be conducted in one or
two phases, the ﬁrst phase data Y 0 need again be integrated out. The information of the
two-phase study is then
EY 0 [−H(Θˆ0;Y 0) + I(Θˆ0;Y 1|Y 0)],
The method including the observed information has previously been employed by Karva-
nen, Kulathinal, and Gasbarra [63].
3.2 Design of pneumococcal colonisation studies
This section considers practical issues in designing pneumococcal colonisation studies in
which the aim is to estimate the dynamics of colonisation (i.e. the rate matrix). A common
framework in such studies is one in which the state of individual i (i = 1, ..., N) is measured
Ki times. The total number of collected samples is K
tot =
∑
iKi. The distribution of the
ﬁrst observation π(Yi(τ
1
i )), needs to be speciﬁed. The subsequent measurements are taken
at times τ 2i , ..., τ
Ki
i and the distribution of samples Yi(τ
j
i ), j = 2, ..., Ki, follows from the
transition probability matrix generated by the rate matrix q(τ) parametrised through a
vector Θ. The duration of the study is T = maxi,j{τ ji }−mini{τ 1i }. The design questions
in this thesis are related to estimation of Θ with minimum variance. To achieve this goal,
one can consider the choice of the number of study subjects (N), the number of repeated
samples per individual (Ki), and the placement of time points τ
j
i , i = 1, ..., N, j = 1, ..., Ki.
The total number of samples (Ktot), determined by the number of individuals N and
the number of repeated samples per individual (K1, ..., KN) is in many cases ﬁxed in
advance. For instance, in pneumococcal applications considered in the articles of this
thesis, the total number of samples could have been limited by the study budget. Ktot
is also related to the absolute level of variance that can be attained for the parameter
estimators (Var(Θˆ)). In this thesis, Ktot is not subject to optimisation and is usually
chosen to be “large.” The reason for this choice is the aim to eliminate the role of the bias
of the estimators in the utility function. The design task under this setting is to minimise
the variance of the estimators over the design space.
Even with a ﬁxed total size, the number of samples can be split in various ways
across individuals N and repeated measurements per individual Ki. The ﬁrst sample
(Yi(τ
1
i )) may have a diﬀerent distribution as compared to the subsequent ones (Yi(τ
j
i )).
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Added information from a new individual may then be diﬀerent from that gained adding
repeated observations for the current study subjects. With regard toKi, unequal numbers
of repeated samples across individuals may be reasonable if, for instance, individuals are
known to diﬀer from each other. In most cases, we assume that individuals are identical
and consider equal numbers of samples across each individual (Ki = K). In Article III,
the choice between N and K, conditioned on Ktot, is considered for the two-state model.
The stationary distribution is a common choice to model the ﬁrst observation π(Yi(τ
1
i )).
In many pneumococcal colonisation studies this assumption is realistic or not of major
concern. Although the prevalence of colonisation is practically zero at birth, it levels oﬀ
in few months after birth and typically remains relatively stable up to several years of age
[64]. For infant studies, the steady-state assumption does not necessarily pose a major
concern if most samples are not taken during the ﬁrst months of life. If the focus is on the
estimation of transition rates soon after birth, i.e., until stationarity is attained, Article
III shows that at least in models with two states optimal equidistant time spacings do
not depend considerably on the initial distribution. However, there may be better per-
forming, non-equidistant designs. For instance, if the non-colonised state is rare under
the stationary distribution and also the initial state for most individuals, optimal time
spacings can be expected to be shorter during the transition phase.
Sometimes the researcher is in a position to inﬂuence the initial distribution. An ex-
ample are challenge studies in which a proportion of subjects are exposed to a certain
condition. It is also possible that the time of ﬁrst observation is deliberately chosen in
order to have indirect inﬂuence on the initial distribution. For example, infants may be
less prone to infections than older children that have been exposed to the infection pres-
sure for a longer time. In Article III that considers two-state models, the optimal initial
distribution is determined and the dependency of optimal time spacings on the initial
distribution is investigated. In Articles IV and V the stationary initial distribution is as-
sumed. We note that although the stationary distribution is realistic in many applications
it is not necessarily the optimal one.
The allocation of time points for observations (τ 1i , ..., τ
KN
N ) is the primary design ques-
tion in Articles III, IV and V. There might be some limitations in how these can be chosen
in practice. One possible limitation in allocating the time points is posed by the duration
of the study T . For instance, a very long study may raise a concern since the subjects
may be lost from the follow-up. Another matter is that the study protocol may not allow
scheduled samples to be collected at arbitrary time points, but rather in certain time win-
dows. Although not necessary, for the processes considered in this thesis, sampling times
that are within a small time window can be considered as observed on the same day. In
this thesis, we do not restrict the duration of the study, but limit to studying designs in
which all individuals are sampled at the same time, i.e., τ j1 = ... = τ
j
N = τ
j, j = 1, ..., K.
Another constraint on the design space regarding the selection of times τ 1, ..., τK is
that investigations are limited to equidistant spacings. The question is then to optimise
the time spacing t between any two consecutive observations. Because constant transition
rates are assumed and the usual scenarios consider the stationary initial distribution, the
restriction to equidistant designs is not a further limitation. A heuristic reasoning for
this is that, with the stationary initial distribution and constant rates, each repeated
sample has the same optimal time spacing when optimised separately. Thus, it is obvious
that when all samples are optimised together, they still have the same optimal time
spacing. Based on the numerical analyses by Albert and Brown [27], this also holds true
for models with two states and two constant rates. When the rates are not constant or
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the initial distribution the stationary one, equidistant designs are not necessarily optimal.
To optimise the time spacings between consecutive observations, it is then necessary to
go through all possible allocations of possible repeated samples. This forms a huge design
space if the number of repeated samples per individual is not very small. In practice, it
may be possible to investigate only certain types of allocation schemes based on intuitive
reasoning.
4 Computational details
Because of the need to integrate over missing data, inference on the model parameters in
Articles I, II, and V could not be performed using standard packages in statistical software
such as R or Matlab®. In these articles, Markov Chain Monte Carlo methods with the
Metropolis-Hastings algorithm were employed to draw samples from the posterior distri-
bution of the model parameters. In Articles III and IV, obtaining maximum likelihood
estimates was straightforward, but the computational burden came from the minimisa-
tion of the variances of the estimators in a large space of candidate designs. This section
highlights some computational aspects of the statistical methods used in this thesis.
In Articles II − V, data were missing by design and the unobserved part of the pro-
cess between any two consecutive observations was integrated with the use of the matrix
logarithm function. This was possible due to the assumption of time-homogeneous tran-
sition rates. In Article I, such missing data were handled using an alternate approach.
In particular, statistical inferences were based on the continuous-time likelihood (1) af-
ter constructing ﬁxed episodes of being susceptible or colonised by one of the serotypes
in the model. The construction of episodes was based on discrete-time data, assuming
that the process makes a minimum number of state changes between any two consecutive
observations. In practice, this meant that at most one unobserved state was needed to
be augmented in between any two consecutive observations. The augmented state and
the change point where one episode ends and a new one starts were treated as random
variables.
Article II involved another type of problem in which the missing data distribution
depends on the underlying unobserved state. In this study, it was acknowledged that
two serotypes simultaneously colonising the same host may have been detected with less
than 100% sensitivity. A recursive algorithm that built all possible transition paths,
i.e. considered the possibility that any observation of a singly colonised state might
represent a doubly colonised one, was employed. Because it would have been diﬃcult
to estimate the sensitivity to observe two simultaneously colonising serotypes, a range of
ﬁxed values of the sensitivity was used. This method proved to be computationally rather
slow. An alternative method known as the Viterbi algorithm that does not consider all
possible transition paths for the underlying hidden state, but only the one with maximum
likelihood, would probably have been suﬃcient.
In Articles III, IV and V, the minimisation of the variance of the rate estimators was
of particular interest. In Article I, the variance was based on the Fisher information,
evaluated numerically in Matlab® using an analytical but lengthy expression that was
derived using symbolic calculation in Maple®. Due to the large number of parameters in
the models of Article IV, the Fisher information was not be derived analytically. Instead,
data were sampled repeatedly using a model with the true parameter values. For each
iteration of data, the maximum likelihood estimates were derived. The measure of un-
certainty in the estimates was evaluated as the average squared distance of the estimates
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from their true values. In Article V, posterior distributions of the model parameters were
sampled using the Metropolis-Hastings algorithm. The measure of uncertainty was based
on quantiles of these samples.
Article V considered a hierarchical Bayesian model to estimate vaccine eﬃcacy allow-
ing a heterogeneous response to vaccination at the individual level. At the population
level, the parameters included the absolute and relative transition rates that were assumed
to be equal and constant across all individuals. Individual-level parameters were needed to
account for possible diﬀerences across individuals in their response to vaccination. There
are multiple ways to implement the same model. We employed an explicit random eﬀect
that was assigned for each individual. This variable followed a speciﬁed prior distribu-
tion with population level parameters. The population level parameters had their own
hyperprior. In the Metropolis-Hastings algorithm that was used, the explicit individual-
level random eﬀects were updated at each iteration similarly as were the population level
parameters.
5 Summary of the main ﬁndings
Markov processes with a ﬁnite state space can be used to model countless phenomena in
many ﬁelds of science. Therefore, researchers often encounter the problem of estimating
transition rates governing the dynamics of such processes. In many applications, the
estimation of transition rates needs to be based on a set of repeated measurements of
the current status of the process. Study designs for collecting such data may have a
particularly important role regarding how well these rates can be estimated.
An example of an estimation problem concerning the transition rates of a ﬁnite state
Markov process is pneumococcal colonisation. The motivation to consider this problem
in this thesis came from the PneumoCarr project (2006 − 2011), which investigated the
possibility of using vaccine eﬃcacy against colonisation as part of the licensure process for
pneumococcal vaccines [22]. Already at the time of initiation of the PneumoCarr project
there were concerns that serotypes for which the pneumococcal conjugate vaccines provide
no protection would eventually replace the diminished colonisation and disease by the
vaccine serotypes. New vaccines could thus be useful in the future. The likely reason for
such replacement is within-host competition between pneumococcal serotypes or strains,
but at the time this phenomenon was poorly understood.
The Markov process approach is suitable for studying competition between pneumo-
coccal strains. In this thesis, the new feature in analysing pneumococcal competition
was the deﬁnition of competition through states in which two serotypes simultaneously
colonise the same host. Conventional sampling methods had not been able to detect more
than one serotype per sample, not allowing this type of deﬁnition for competition when
analysing observed data sets [30, 65]. The research made in this thesis (Article I) provided
evidence for strong competition which was found to work in a way that serotype already
colonising the human nasopharynx reduces the acquisition rate of other serotypes. This
ﬁnding can be important for predicting replacement patterns because disease is often a
consequence of a newly acquired colonisation episode [66].
Although new data with observations on simultaneous pneumococcal colonisation were
available for this thesis, there were concerns that competition is estimated too strong if
the sensitivity to detect both simultaneously colonising serotypes is poor but this is not
accounted for in the analysis. Methodologically, this type of problem can be dealt with
the use of a hidden Markov model. In the application of such models (Article II), time
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spacings between consecutive observations were found to have an important role regarding
what type of bias would occur in the estimation of competition when assuming too high
sensitivity of detecting two simultaneously colonising serotypes. In particular, with short
time spacings the estimation of competition that works through reducing acquisition rates
was found to be unbiased even when analysing the data under an incorrect assumption
of perfect sensitivity to detect double colonisation. The re-analyses of the pneumococcal
colonisation data accounting for the possibility to detect simultaneous colonisation with
less than 100% sensitivity conﬁrmed earlier ﬁndings about strong competition that works
through reducing acquisition.
New pneumococcal colonisation studies may be important in the future, and it may
be of particular interest to investigate the dynamics of colonisation under the eﬀect of
new pneumococcal vaccines. In previous pneumococcal colonisation studies little or no
justiﬁcation for choosing a particular study design has been presented. The most obvi-
ous question concerns time spacings between consecutive samples that has varied across
studied with no apparent reasoning. These notions acted as the motivation to develop a
better design methodology for future colonisation studies.
An approximation to the optimal time spacing to collect repeated samples to estimate
transition rates was presented as the reciprocal of the maximal sum of rates inwards and
outwards from any state in the model (Articles III and IV). This approximation is applica-
ble when the rates are constant and do not diﬀer markedly from each other. Furthermore,
when the rates are constant and the initial distribution is stationary, the same time spac-
ing is applicable for any two consecutive samples in a study (equidistant design). This
thesis treats pneumococcal colonisation as an example. However, the underlying model in
Articles III and IV is a general continuous-time Markov process and the suggested designs
are thereby widely applicable.
An important aim in studies of pneumococcal vaccines and any new vaccine is to
predict the impact of vaccination in a population. In these predictions, it is substantial to
correctly specify the type of vaccine protection. It is possible that a vaccine gives complete
protection against infection or it reduces the instantaneous risk to acquire infection with
a certain magnitude. These two types of vaccines may give the same average protection
across individuals but when given to a population they may have diﬀerent impact. If
the speciﬁcation of the type of vaccine protection needs to be determined by estimation
using repeated current status data, the time spacing between consecutive samples has
an important role. An important ﬁnding in this thesis (Article V) was that when the
type of vaccine protection needs to be inferred from data, the time spacing should be
optimized as if the vaccine would not give complete protection to any individual. The
number of repeated samples per individual should then be large enough to assure that,
if not completely protected from the infection, one is observed with the infection at least
once.
There remains several interesting questions regarding the design of longitudinal studies
in which observed discrete-time data arises from an underlying continuous-time stochastic
process. For studies in which transmission of infectious diseases is investigated, optimal
time spacing between consecutive observations would be useful. In transmission studies,
the same time spacing between all samples would likely not be optimal because of time
varying exposure. This study addressed rather general aspects of data collection for
Markov processes. It would be interesting to compare these results to highly speciﬁc
study designs that account for a variety of study speciﬁc factors.
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6 Article summaries
Article I, Between-strain competition in acquisition and clear-
ance of pneumococcal carriage − epidemiologic evidence from a
longitudinal study of day-care children
A longitudinal dataset of pneumococcal colonisation in unvaccinated day-care children
was analysed to investigate within-host competition between pneumococcal strains. The
main research questions were whether colonisation with one serotype decreases the acqui-
sition rate of other serotypes as compared to acquisition when uncolonised and whether
concurrent colonisation of two serotypes enhances the clearance of these types as compared
to the situation when serotypes colonise the host one at a time.
Statistical inference was based on a likelihood that assumed continuous-time observa-
tions. Because the actual observations were discrete-time, episodes of being susceptible
or colonised with one or two of the serotypes were ﬁrst constructed. In this construction,
it was assumed that during the unobserved time period between any two consecutive ob-
servations, the colonisation process made a minimum number of state changes required
for compatibility with the observations.
Ongoing pneumococcal colonisation by any one serotype was found to protect from
further acquisitions by other serotypes. Clearance of any single serotype was not aﬀected
by concurrent colonisation with other serotypes. To our knowledge, this was the ﬁrst study
providing empirical evidence of between-strain competition deﬁned through concurrent
colonisation by two serotypes.
Article II, Competition between Streptococcus pneumoniae strains:
implications for vaccine-induced replacement in colonization and
disease
The aim of this study was to repeat the analysis of Article I and, with use of hidden
Markov models to this novel application, take into account the possibility that imperfect
sensitivity to detect multiple simultaneously colonising serotypes may aﬀect the estimates
of competition between pneumococcal strains. In addition to the data set already analysed
in Article I, two new data sets were employed to investigate between-strain competition in
epidemiologically diﬀerent settings. Simulation studies were used to gain further insight
into how inferences may be biased when wrongly assuming that multiple colonisation has
been observed with a high sensitivity. Diﬀerent time spacings for sample collection were
considered in the simulation studies.
A hidden Markov model was utilised to allow the possibility that when one serotype
was observed, this actually arose from a true hidden state in which two serotypes simulta-
neously colonised the same host. For the probability to observe two serotypes (detection
sensitivity), a range of given values was used. Unlike in Article I, the estimation of
transition rates was not based on ﬁxed episodes.
When assuming 100% sensitivity to detect two simultaneously colonising serotypes,
competition was found to be strong in each of the three datasets, in agreement with the
ﬁndings in Article I. Simulation studies showed that competition is estimated too strong
if the sensitivity of detecting simultaneous colonisation is assumed too high. However,
the ﬁnding of strong competition remained in all three datasets even when assuming 50%
sensitivity.
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Article III, Optimal designs for epidemiologic longitudinal studies
with binary outcomes
Design questions for collecting longitudinal data under Markov transition models with
two states were considered. The rates were estimated using a sequence of observations
made at discrete times. The aim was to minimise the variance of either one or both of
the transition rate estimators. Particular design questions included the choice of time
interval between consecutive observations, the initial distribution of the study subjects
and the choice between the number of subjects versus repeated observations per subject.
In sequential designs, an upcoming phase of the study was designed using estimates of
parameters obtained from data collected in the previous phases.
The covariance matrix for the estimators was derived as the inverse of the Fisher infor-
mation matrix. Optimal designs were derived by minimising the trace of the covariance
matrix (A-optimal design) or by minimising either of the two diagonal elements of the
matrix. In sequential designs, the sample based Fisher information matrix (observed in-
formation) was used as the measure of accumulated information from the data that have
already been collected.
It was shown that the reciprocal of the sum of the two rates in the model is a good
approximation for the optimal time spacing between consecutive measurements. The
approximation is similar to what had been presented previously, but its applicability
was extended by this study. A completely new result was the ﬁnding that the initial
distribution is important in studies where relatively few repeated samples per individual
are collected and that large studies can beneﬁt greatly from sequential designs. It is
important, however, that enough samples are collected in the ﬁrst phase in order to have
a high probability to improve the initial design.
Article IV, Optimal observation times for multi-state Markov
models − applications to pneumococcal colonisation studies
The main question was to optimise the time spacing between consecutive samples that
arise from a Markov transition model with 2, 3, or 4 states. In addition to considering
the estimation of transition rates for one homogeneous group, the estimation of rate
ratios based on two groups in a comparative study was of interest. Due to the high
dimensionality of the problem, arising from allowing many states in the model, some
regularity conditions such as the stationary distribution were assumed. Regarding the
fact that designs depended on the model parameters, prior distributions were compared
to the use of an initial guess of a single value.
The performance of each design was based on the mean squared distance of a sample of
parameter estimates from the true parameter values. For the time spacing that minimises
the mean squared distance, an approximation was given as the inverse of the maximal
sum of the rates inwards and outwards from any particular state in the model. The
approximation is easy to apply in practice and is eﬃcient for models with up to at least 4
states when the rates diﬀer from each other less than 10-fold. This result generalises the
approximation presented in Article III to models with multiple states.
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Article V, Estimation and interpretation of heterogeneous vac-
cine eﬃcacy against recurrent infections
The problem of estimating vaccine eﬃcacy based on relative transition rates in continuous-
time Markov processes in two groups of individuals (vaccinated and unvaccinated) was
considered. In the model, recurrent infections with multiple subtypes were considered
and estimation was based on discrete-time data. In a group of vaccinated individuals, one
can receive complete, partial, or no protection against the infection. A speciﬁc research
question was whether proportions of individuals gaining complete, incomplete or no pro-
tection can be estimated using discrete-time data. Among those who receive incomplete
protection, the average magnitude of protection was also one of the parameters to be
estimated.
A hierarchical Bayesian approach was employed. General infection dynamics were
described using a multistate Markov model with population-level parameters. Individual-
level diﬀerences in vaccine response were modelled as random eﬀects. Posterior distri-
butions of the model parameters were sampled using the Metropolis-Hastings algorithm.
The performance of each design in the estimation of vaccine eﬃcacy was based on the
mean and uncertainty in the samples from the posterior distribution.
The best performing time spacing in the estimation of vaccine eﬃcacy depends on
the type of vaccine protection. Long time spacings perform better in the estimation
of the proportion of individuals who are completely protected. By comparison, shorter
time spacings perform better in the estimation of the average magnitude of incomplete
protection. If the estimation of the type of vaccine protection fails, appropriate summary
measures may still be estimable.
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